Teknova to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Teknova (Nasdaq: TKNO) will participate in two upcoming investor conferences: the Stephens Annual Investment Conference from November 15-17, 2022, and the Piper Sandler 34th Annual Healthcare Conference from November 29-December 1, 2022. At these events, CEO Stephen Gunstream and CFO Matt Lowell will discuss company highlights, product offerings, and market opportunities. Live webcasts will be available on the company's website for 90 days post-event. Teknova focuses on providing custom reagents for drug therapies, vaccines, and diagnostics.

HOLLISTER, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, research, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conferences:

Stephens Annual Investment Conference
November 15 - 17, 2022
Nashville, TN
Fireside Chat: 1:00 p.m. CT, Thursday, November 17, 2022

Piper Sandler 34^th Annual Healthcare Conference
November 29 - December 1, 2022
New York, NY
Company Presentation: 12:50 p.m. ET, Wednesday, November 30, 2022

Stephen Gunstream, Teknova’s President and Chief Executive Officer, and Matt Lowell, Teknova’s Chief Financial Officer, plan to discuss Company highlights, their product portfolio, market trends, key growth drivers, and long-term market opportunities.

Live audio webcasts for each conference may be accessed from the Investor Relations section of the Company’s website: https://ir.teknova.com/. The webcasts will be available on the Company’s website for approximately 90 days after each event.

About Teknova
Teknova is expediting clinical breakthroughs in life sciences by providing custom products and reagents for drug therapies, novel vaccines, and molecular diagnostics. With a focus on agility and customization, Teknova delivers research-grade and GMP products, including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents for a multitude of established and emerging applications, including cell and gene therapy, mRNA therapeutics, genomics, and synthetic biology. Teknova's proprietary processes enable the manufacture and delivery of high-quality, custom, made-to-order products with short turnaround times and at scale across all stages of development, including commercialization.

Investor Contacts
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100

Sara Michelmore
MacDougall Advisors
smichelmore@macdougall.bio
+1 781-235-3060

Media Contact
Jenn Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259

FAQ

What are the dates for Teknova's upcoming investor conferences?

Teknova's upcoming investor conferences are from November 15-17, 2022, and November 29-December 1, 2022.

Where will Teknova's investor conferences take place?

The Stephens Annual Investment Conference will be in Nashville, TN, and the Piper Sandler Healthcare Conference will be in New York, NY.

Who will represent Teknova at the upcoming conferences?

Stephen Gunstream, President and CEO, and Matt Lowell, Chief Financial Officer, will represent Teknova.

What topics will be discussed at Teknova's investor conferences?

The discussions will cover company highlights, product portfolio, market trends, and growth opportunities.

How can I access Teknova's conference webcasts?

Live webcasts can be accessed on Teknova's Investor Relations website and will be available for 90 days after each event.